Our work indicates that UA could reverse PTX resistance in breast cancer by modulating miR-149-5p and MyD88 expression, which sheds light on the improvement of breast cancer chemotherapy and provides evidence for further clinical investigation. This evidence concerns the gene MYD88 and breast carcinoma.